Brief: Gensight Biologics Announces Completion Of EUR 5 Mln Capital Increase
Feb 8 (Reuters) - Gensight Biologics SA SIGHT.PA :
* GENSIGHT BIOLOGICS ANNOUNCES COMPLETION OF A EUR 5 MILLION
CAPITAL INCREASE WITH SOFINNOVA PARTNERS, INVUS, UPMC
ENTERPRISES AND HEIGHTS CAPITAL
Source text for Eikon: ID:nBw1Rmhr5a
Further company coverage: SIGHT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gensight Biologics SA
See all newsHealth Rounds: Blindness treatment based on Nobel-winning research shows promise
France's GenSight Biologics H1 net loss widens on higher R&D expenses
Brief: GenSight Biologics H1 Net Income EUR -10.3 Million
France's GenSight Biologics 2025 net loss narrows on reduced R&D spending
Brief: GenSight Biologics FY EPS EUR -0.08